SEQUELLA INC has a total of 32 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are GRINDEKS JOINT STOCK COMPANY, EPIS SA and ERRANT GENE THERAPEUTICS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | United States | 4 | |
#4 | Australia | 3 | |
#5 | Canada | 3 | |
#6 | Israel | 3 | |
#7 | China | 2 | |
#8 | EAPO (Eurasian Patent Organization) | 1 | |
#9 | Hong Kong | 1 | |
#10 | Japan | 1 | |
#11 | Singapore | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Biotechnology |
# | Name | Total Patents |
---|---|---|
#1 | Bogatcheva Elena | 11 |
#2 | Protopopova Marina Nikolaevna | 10 |
#3 | Einck Leo | 10 |
#4 | Sacksteder Katherine | 7 |
#5 | Mulvey Matthew C | 7 |
#6 | Mccombs Candace | 5 |
#7 | Lakowicz Joseph R | 3 |
#8 | Protopopova Marina | 3 |
#9 | Gryczynski Zygmunt | 3 |
#10 | Abugo Omoefe | 3 |
Publication | Filing date | Title |
---|---|---|
CA2825187A1 | Improved methods and compositions for determining the pathogenic status of infectious agents | |
WO2009136965A1 | Compositions and methods comprising capuramycin analogues | |
US2009047658A1 | Methods and compositions for determining the pathogenic status of infectious agents | |
WO2006026404A2 | Assay for detecting tuberculosis in nonhuman primates | |
US2006148904A1 | Anti tubercular drug: compositions and methods | |
US7884097B2 | Methods and compositions comprising diamines as new anti-tubercular therapeutics | |
AU2003228240A1 | Methods of use and compositions for the diagnosis and treatment of infectious disease | |
CN101404986A | Methods of use and compositions for the diagnosis and treatment of infectious disease | |
CA2485592A1 | Anti tubercular drug: compositions and methods | |
WO0037114A2 | Methods and compositions comprising monitoring devices |